Public health impact and cost-effectiveness of introducing MenACWY vaccination strategies in Germany

Public health impact and cost-effectiveness of introducing MenACWY vaccination strategies in Germany

Abstract Background The invasive meningococcal disease (IMD) routine immunization recommendation in Germany is a meningococcal serogroup C (MenC) conjugate vaccine for toddlers aged 12 months with a catch-up for unimmunized up to 17 years. However, there are no recommendations for routine meningococ...

Full description

Saved in:
Bibliographic Details
Main Authors: Katharina Schley, Sabrina Janßen, Shannon M. Sullivan, Eszter Tichy, Jamie Findlow
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Public Health
Subjects:
Invasive meningococcal disease
Vaccination
Public health
Public policy
Germany
MenACWY
Online Access:https://doi.org/10.1186/s12889-025-21491-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items